Allosteric Modulation of Mitochondrial Complex I By Succinylation of NDUFV2 Subunit Under Hyperglycemic Conditions: Implications for Ros-Mediated Β-Cell Apoptosis in Type 2 Diabetes

Authors

  • Zainab Nasser Hussein The General Directorate of Education in Wasit, Al-Suwayrah Education Directorate – Al-Zubaidiyah High School for Outstanding Students, Iraq

DOI:

https://doi.org/10.17977/um067v6i62026p1

Keywords:

Type 2 Diabetes Mellitus, Pancreatic β-cells, NDUFV2 Succinylation, Mitochondrial Complex I, Reactive Oxygen Species, Apoptosis, SIRT5, Hyperglycemia, Mitochondrial Dysfunction

Abstract

Background: Type 2 diabetes mellitus is a disease of progressively dysfunctional pancreatic β-cells, including β-cell apoptosis, where mitochondrial oxidative stress is a key pathogenic factor. Nevertheless, the molecular pathway which connects chronic hyperglycemia with mitochondrial Complex I dysfunction is not fully understood. Aim: The study examined the role of hyperglycemia-induced succinylation of the NDUFV2 subunit as an allosteric modulator of mitochondrial Complex I, increased reactive oxygen species (ROS) generation, and β-cell death. Methodology: A mechanistic study was planned with the use of INS-1 β-cells under normoglycemic (5.5 mmol/L) and hyperglycemic (25 mmol/L) conditions after 48 h of incubation, with osmotic controls, antioxidant treatment, SIRT5 overexpression, and site-directed mutagenesis of NDUFV2. Immunoprecipitation, immunoblotting and LC-MS/MS were used to assess NDUFV2 succinylation, while standard mitochondrial and cell-death assays were used to measure Complex I activity, oxygen consumption, ATP production, membrane potential, ROS generation and apoptosis. Results: Hyperglycemia elevated NDUFV2 succinylation 2.71-fold, mitochondrial ROS 2.31-fold, and caspase-3/7 activity 2.87-fold, and decreased Complex I activity to 58% and ATP to 24.8 nmol/mg protein. The K81R mutant restored Complex I activity to 88%, lowered ROS to 1.34-fold, and enhanced viability to 89%. Conclusion: NDUFV2 succinylation may be one of the mechanistic causes of Complex I impairment and ROS-induced β-cell apoptosis in type 2 diabetes.

References

Ashcroft, F. M., & Rorsman, P. (2012). Diabetes mellitus and the β cell: The last ten years. Cell, 148(6), 1160–1171. https://doi.org/10.1016/j.cell.2012.02.010

Birrell, J. A., Morina, K., Bridges, H. R., Friedrich, T., & Hirst, J. (2013). Investigating the function of [2Fe-2S] cluster N1a, the off-pathway cluster in complex I, by manipulating its reduction potential. Biochemical Journal, 456(1), 139–146. https://doi.org/10.1042/BJ20130606

Brand, M. D. (2016). Mitochondrial generation of superoxide and hydrogen peroxide as the source of mitochondrial redox signaling. Free Radical Biology and Medicine, 100, 14–31. https://doi.org/10.1016/j.freeradbiomed.2016.04.001

Chen, Y., Liu, X., Liu, Y., Li, Y., Li, D., Mei, Z., & Deng, Y. (2025). Mitochondrial quality control in diabetes mellitus and complications: Molecular mechanisms and therapeutic strategies. Cell Death & Disease, 16(1), 652. https://doi.org/10.1038/s41419-025-07936-y

Dalle, S., Abderrahmani, A., & Renard, E. (2023). Pharmacological inhibitors of β-cell dysfunction and death as therapeutics for diabetes. Frontiers in Endocrinology, 14, 1076343. https://doi.org/10.3389/fendo.2023.1076343

Darwish, R., Alcibahy, Y., Abu-Sharia, G., & Butler, A. E. (2025). β-Cell mitochondrial dysfunction: Underlying mechanisms and potential therapeutic strategies. Cells, 14(23), 1861. https://doi.org/10.3390/cells14231861

Dludla, P. V., Mabhida, S. E., Ziqubu, K., Nkambule, B. B., Mazibuko-Mbeje, S. E., Hanser, S., Basson, A. K., Pheiffer, C., & Kengne, A. P. (2023). Pancreatic β-cell dysfunction in type 2 diabetes: Implications of inflammation and oxidative stress. World Journal of Diabetes, 14(3), 130–146. https://doi.org/10.4239/wjd.v14.i3.130

Eguchi, N., Vaziri, N. D., Dafoe, D. C., & Ichii, H. (2021). The role of oxidative stress in pancreatic β cell dysfunction in diabetes. International Journal of Molecular Sciences, 22(4), 1509. https://doi.org/10.3390/ijms22041509

Fiedorczuk, K., Letts, J. A., Degliesposti, G., Kaszuba, K., Skehel, M., & Sazanov, L. A. (2016). Atomic structure of the entire mammalian mitochondrial complex I. Nature, 538(7625), 406–410. https://doi.org/10.1038/nature19794

Gerber, P. A., & Rutter, G. A. (2017). The role of oxidative stress and hypoxia in pancreatic beta-cell dysfunction in diabetes mellitus. Antioxidants & Redox Signaling, 26(10), 501–518. https://doi.org/10.1089/ars.2016.6755

Hirst, J. (2013). Mitochondrial complex I. Annual Review of Biochemistry, 82, 551–575. https://doi.org/10.1146/annurev-biochem-070511-103700

Hou, X., Zhu, L., Xu, H., Shi, J., & Ji, S. (2024). Dysregulation of protein succinylation and disease development. Frontiers in Molecular Biosciences, 11, 1407505. https://doi.org/10.3389/fmolb.2024.1407505

International Diabetes Federation. (2025). IDF Diabetes Atlas (11th ed.). https://diabetesatlas.org/resources/idf-diabetes-atlas-2025/

Kampjut, D., & Sazanov, L. A. (2020). The coupling mechanism of mammalian respiratory complex I. Science, 370(6516), eabc4209. https://doi.org/10.1126/science.abc4209

Kulkarni, A., Muralidharan, C., May, S. C., Tersey, S. A., & Mirmira, R. G. (2023). Inside the β cell: Molecular stress response pathways in diabetes pathogenesis. Endocrinology, 164(1), bqac184. https://doi.org/10.1210/endocr/bqac184

Lancaster, M. S., Kim, B., Doud, E. H., Tate, M. D., Sharify, A. D., Gao, H., Chen, D., Simpson, E., Gillespie, P., Chu, X., Miller, M. J., Wang, Y., Liu, Y., Mosley, A. L., Kim, J., & Graham, B. H. (2023). Loss of succinyl-CoA synthetase in mouse forebrain results in hypersuccinylation with perturbed neuronal transcription and metabolism. Cell Reports, 42(10), 113241. https://doi.org/10.1016/j.celrep.2023.113241

Mukai, E., Fujimoto, S., & Inagaki, N. (2022). Role of reactive oxygen species in glucose metabolism disorder in diabetic pancreatic β-cells. Biomolecules, 12(9), 1228. https://doi.org/10.3390/biom12091228

Newsholme, P., Cruzat, V. F., Keane, K. N., Carlessi, R., & Homem de Bittencourt, P. I., Jr. (2016). Molecular mechanisms of ROS production and oxidative stress in diabetes. Biochemical Journal, 473(24), 4527–4550. https://doi.org/10.1042/BCJ20160503C

Okoye, C. N., Koren, S. A., & Wojtovich, A. P. (2023). Mitochondrial complex I ROS production and redox signaling in hypoxia. Redox Biology, 67, 102926. https://doi.org/10.1016/j.redox.2023.102926

Pamplona, R., Jové, M., Mota-Martorell, N., & Barja, G. (2021). Is the NDUFV2 subunit of the hydrophilic complex I domain a key determinant of animal longevity? The FEBS Journal, 288(23), 6652–6673. https://doi.org/10.1111/febs.15714

Park, I. R., Chung, Y. G., & Won, K. C. (2025). Overcoming β-cell dysfunction in type 2 diabetes mellitus: CD36 inhibition and antioxidant system. Diabetes & Metabolism Journal, 49(1), 1–12. https://doi.org/10.4093/dmj.2024.0796

Prasad, M. K., Mohandas, S., & Ramkumar, K. M. (2023). Dysfunctions, molecular mechanisms, and therapeutic strategies of pancreatic β-cells in diabetes. Apoptosis, 28(7–8), 958–976. https://doi.org/10.1007/s10495-023-01854-0

Rardin, M. J., He, W., Nishida, Y., Newman, J. C., Carrico, C., Danielson, S. R., Guo, A., Gut, P., Sahu, A. K., Li, B., Uppala, R., Fitch, M., Riiff, T., Zhu, L., Zhou, J., Mulhern, D., Stevens, R. D., Ilkayeva, O. R., Newgard, C. B., … Verdin, E. (2013). SIRT5 regulates the mitochondrial lysine succinylome and metabolic networks. Cell Metabolism, 18(6), 920–933. https://doi.org/10.1016/j.cmet.2013.11.013

Read, A. D., Bentley, R. E., Archer, S. L., & Dunham-Snary, K. J. (2021). Mitochondrial iron-sulfur clusters: Structure, function, and an emerging role in vascular biology. Redox Biology, 47, 102164. https://doi.org/10.1016/j.redox.2021.102164

Sreedhar, A., Wiese, E. K., & Hitosugi, T. (2020). Enzymatic and metabolic regulation of lysine succinylation. Genes & Diseases, 7(2), 166–171. https://doi.org/10.1016/j.gendis.2019.09.011

Supale, S., Li, N., Brun, T., & Maechler, P. (2012). Mitochondrial dysfunction in pancreatic β cells. Trends in Endocrinology & Metabolism, 23(9), 477–487. https://doi.org/10.1016/j.tem.2012.06.002

Szczepanowska, K., Senft, K., Heidler, J., Herholz, M., Kukat, A., Höhne, M. N., Hofsetz, E., Becker, C., Kaspar, S., Giese, H., Zwicker, K., Guerrero-Castillo, S., Baumann, L., Kauppila, J., Rumyantseva, A., Müller, S., Frese, C. K., Brandt, U., Riemer, J., … Trifunovic, A. (2020). A salvage pathway maintains highly functional respiratory complex I. Nature Communications, 11(1), 1643. https://doi.org/10.1038/s41467-020-15467-7

Weinert, B. T., Schölz, C., Wagner, S. A., Iesmantavicius, V., Su, D., Daniel, J. A., & Choudhary, C. (2013). Lysine succinylation is a frequently occurring modification in prokaryotes and eukaryotes and extensively overlaps with acetylation. Cell Reports, 4(4), 842–851. https://doi.org/10.1016/j.celrep.2013.07.024

Zaher, A., & Stephens, S. B. (2025). Breaking the feedback loop of β-cell failure: Insight into the pancreatic β-cell’s ER–mitochondria redox balance. Cells, 14(6), 399. https://doi.org/10.3390/cells14060399

Zhang, Y., Bharathi, S. S., Rardin, M. J., Lu, J., Maringer, K. V., Sims-Lucas, S., Prochownik, E. V., Gibson, B. W., & Goetzman, E. S. (2017). Lysine desuccinylase SIRT5 binds to cardiolipin and regulates the electron transport chain. Journal of Biological Chemistry, 292(24), 10239–10249. https://doi.org/10.1074/jbc.M117.785022

Downloads

Published

02-06-2026

How to Cite

Hussein, Z. N. . (2026). Allosteric Modulation of Mitochondrial Complex I By Succinylation of NDUFV2 Subunit Under Hyperglycemic Conditions: Implications for Ros-Mediated Β-Cell Apoptosis in Type 2 Diabetes. Jurnal MIPA Dan Pembelajarannya, 6(6), 1. https://doi.org/10.17977/um067v6i62026p1

Issue

Section

Articles